Results 21 to 30 of about 120,449 (305)

Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: a case report [PDF]

open access: yes, 2018
Paraganglioma (PGL) is a rare neuroendocrine tumor. Currently, the malignancy is defined as the presence of metastatic spread at presentation or during follow-up.
Aschelter, Am   +10 more
core   +1 more source

Lipid peroxidation in rats treated with vincristine sulphate and nandrolone decanoate

open access: yesArquivo Brasileiro de Medicina Veterinária e Zootecnia, 2011
Brain and serum lipid peroxidation was studied in rats treated with vincristine sulphate and different doses of nandrolone decanoate. Thirty rats were distributed into six groups (n=5). The treatments were applied once a week for two weeks.
D.B Martins   +9 more
doaj   +1 more source

Recurrent vincristine‐associated fever in a child with Wilms tumor

open access: yesCancer Reports, 2022
Background Fever is a common complaint among children with an underlying oncologic diagnosis, especially during chemotherapy courses and periods of neutropenia.
Eman T. Al‐Antary, Sarah Ramiz
doaj   +1 more source

Vincristine-induced peripheral neuropathic pain and expression of transient receptor potential vanilloid 1 in rat

open access: yesJournal of Pharmacological Sciences, 2017
The clinical anti-cancer efficacy of vincristine is limited by the development of dose-dependent peripheral neuropathy. Up-regulation of transient receptor potential vanilloid 1 (TRPV1) is correlated with peripheral neuropathy following anti-cancer drug ...
Terumasa Chiba   +6 more
doaj   +1 more source

The Effect of Vincristine on Hypoxic, Apoptotic, and Autophagic Gene Expressions in Gastric Cancer Cells under Hypoxic Conditions [PDF]

open access: yesMiddle East Journal of Cancer, 2023
Background: Apoptosis and autophagy functions are known as death-inducing mechanisms. Vincristine (VCR) is a chemotherapeutic drug that binds with tubulin dimers and induces apoptosis in cancer cells. Furthermore, VCR protects cancer cells from apoptosis,
Meliha Irmak-Yazicioglu, Betül Ceylaner
doaj   +1 more source

Intratumoral recombinant human interferon alpha‐2a and vincristine combination therapy in canine transmissible venereal tumour

open access: yesVeterinary Medicine and Science, 2018
Canine transmissible venereal tumour (CTVT) is a naturally occurring contagious neoplasm of dogs located mainly on the external genitalia of both sexes. The course of vincristine chemotherapy, the most effective and practical therapy, is affected by the ...
Halit Kanca   +5 more
doaj   +1 more source

Vincristine Promotes Transdifferentiation of Fibroblasts Into Myofibroblasts via P38 and ERK Signal Pathways

open access: yesFrontiers in Pharmacology, 2022
Background: Vincristine (VCR) is used in the clinic as an anti-tumor drug. VCR can cause pulmonary fibrosis (PF), leading to respiratory failure. The transformation of fibroblasts into myofibroblasts may play a key role in PF. The present study attempted
Hui Xu   +11 more
doaj   +1 more source

Owner perceptions of their cat's quality of life when treated with a modified University of Wisconsin-Madison protocol for lymphoma [PDF]

open access: yes, 2017
The objectives of this study were to assess owner perceptions of their cat’s quality of life during treatment for lymphoma with a doxorubicin-containing multi-agent chemotherapy protocol, whether various health-related parameters correlated with quality ...
Anneliese J Stell   +7 more
core   +1 more source

Vincristine delays gastric emptying and gastrointestinal transit of liquid in awake rats

open access: yesBrazilian Journal of Medical and Biological Research, 2009
We evaluated the effects of vincristine on the gastrointestinal (GI) motility of awake rats and correlated them with the course of vincristine-induced peripheral neuropathy.
A.A. Peixoto Júnior   +7 more
doaj   +1 more source

A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response [PDF]

open access: yes, 2019
The ImbruVeRCHOP trial is an investigator-initiated, multicenter, single-arm, open label Phase I/II study for patients 61-80 years of age with newly diagnosed CD20+ diffuse large B-cell lymphoma and a higher risk profile (International Prognostic Index ...
Anagnostopoulos, Ioannis   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy